1. Home
  2. FATE vs STEX Comparison

FATE vs STEX Comparison

Compare FATE & STEX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Fate Therapeutics Inc.

FATE

Fate Therapeutics Inc.

HOLD

Current Price

$1.14

Market Cap

139.6M

Sector

Health Care

ML Signal

HOLD

STEX

Streamex Corp.

N/A

Current Price

$1.89

Market Cap

297.8M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
FATE
STEX
Founded
2007
2009
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
139.6M
297.8M
IPO Year
2013
N/A

Fundamental Metrics

Financial Performance
Metric
FATE
STEX
Price
$1.14
$1.89
Analyst Decision
Buy
Strong Buy
Analyst Count
6
1
Target Price
$4.10
$12.00
AVG Volume (30 Days)
1.4M
1.5M
Earning Date
05-29-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
29.88
N/A
EPS
N/A
N/A
Revenue
$6,646,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$1.05
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.66
$1.81
52 Week High
$1.94
$7.44

Technical Indicators

Market Signals
Indicator
FATE
STEX
Relative Strength Index (RSI) 39.50 35.19
Support Level $0.96 N/A
Resistance Level $1.16 $3.68
Average True Range (ATR) 0.11 0.17
MACD -0.04 0.01
Stochastic Oscillator 5.10 14.17

Price Performance

Historical Comparison
FATE
STEX

About FATE Fate Therapeutics Inc.

Fate Therapeutics Inc is a clinical-stage biopharmaceutical company based in the United States. It is engaged in the development of programmed cellular immunotherapies for cancer and autoimmune disorders. The company's cell therapy pipeline is comprised of NK- and T-cell immuno-oncology programs, including off-the-shelf engineered product candidates derived from clonal master iPSC lines, and immuno-regulatory programs, including product candidates to prevent life-threatening complications in patients.

About STEX Streamex Corp.

Streamex Corp is a vertically integrated technology and infrastructure company. It is focused on the tokenization and digitalization of real-world assets. The group provides institutional-grade solutions that bring traditional commodities and assets on-chain through secure, regulated, and yield-bearing financial instruments. It is committed to delivering transparent, scalable, and compliant digital asset solutions that bridge the gap between traditional finance and blockchain-enabled markets.

Share on Social Networks: